News
When the Covid-19 pandemic hit, the then-Stanford professor was one of the loudest critics of lockdowns, school closures and ...
Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
Vinay Prasad, named to lead the FDA agency tasked with regulating vaccines and gene therapy, has made controversial comments ...
Leaders at the FDA, HHS and elsewhere are putting guardrails around COVID-19 boosters, which could mean delayed shots or ...
The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.
For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.
6d
MedPage Today on MSNWho Is Trump's Surgeon General Pick? Drug Cost Executive Order; Combo Flu-COVID VaxWho is Casey Means, MD? A profile of the new nominee for U.S. Surgeon General. (AP) President Trump is expected to sign an ...
Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...
Placebo testing has been part of the process since the 1940s. It’s unclear what additional measures would achieve — but it may slow development.
A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...
MSNBC on MSN5d
'Show me the data': FDA commissioner reacts to question about Covid vaccine for young AmericansVaccine maker Novavax is seeking to convert the 2022 emergency authorization of its Covid-19 vaccine into full approval. Yet ...
Novavax sees pathway to FDA approval after post-marketing commitments ... investors spooked by the delay of full approval of its COVID vaccine shot by U.S. regulators saying that it sees a pathway ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results